Rheumatic Disease Clinics of North America

Papers
(The median citation count of Rheumatic Disease Clinics of North America is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)
ArticleCitations
Pediatric Rheumatology Comes of Age: Part II88
Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases68
Implementation Science in Pediatric Rheumatology: A Path to Health Equity47
Copyright34
Contents34
Immune Checkpoint Inhibitor-induced Inflammatory Arthritis28
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis24
Advancing Gastrointestinal Microbiota Research in Systemic Sclerosis24
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children23
Osteoarthritis Treatment Guidelines from Six Professional Societies22
Forthcoming Issues21
Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy20
Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica19
Exploring the Mucosal Immune Response in Axial Spondyloarthritis Through Immunoglobulin A-Coated Microbiota19
Copyright19
COPA Syndrome from Diagnosis to Treatment18
Contributors17
Lessons Learned from the COVID-19 Pandemic in Rheumatology15
Venous Thromboembolism in the Inflammatory Rheumatic Diseases15
Taxonomy of Quality of Care Indicators15
B Cells in Systemic Lupus Erythematosus14
The Short and Long of COVID-1914
T Cells in Systemic Lupus Erythematosus14
Imaging Challenges and Developments in Large-vessel Vasculitis14
Newer Immunosuppressants for Rheumatologic Disease13
Contents13
Vaccinations in Patients with Rheumatic Disease13
It Takes Oysters to Generate Pearls12
Expanding the Treatment Team11
Contents11
Multisystem Inflammatory Syndrome in Children and Kawasaki Disease11
The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events11
De novo Connective Tissue Disorders as Immune-related Adverse Events11
Primary Cardiac Involvement in Systemic Sclerosis10
Copyright10
Pulmonary Hypertension Associated with Connective Tissue Disease10
Uveitis in Children and Adolescents9
Rheumatology Pearls for the Primary Care Physician9
Scleroderma: Best Approaches to Patient Care9
Assessing Patient-Reported Outcomes in Pediatric Rheumatic Diseases8
Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis8
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 20198
Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease8
Chronic Nonbacterial Osteomyelitis7
Cardiac MRI in Rheumatic Disease7
Systemic Lupus Erythematosus Classification and Diagnosis7
Daniel J McCarty, MD: A Giant of Rheumatology7
Charles L Christian7
COVID-19 and Rheumatology7
Preventative Care in Scleroderma6
A Guide to Contemporary Clinical Practice Guidelines6
Contents6
The Giants of Rheumatology at Johns Hopkins: Lawrence E Shulman, MD, PhD and Mary Betty Stevens, MD6
Contributors6
Contributors6
Imaging of the Major Salivary Glands in Rheumatic Disease6
Copyright6
Guideline Development and Implementation in Rheumatic Disease6
Heart Failure in Rheumatic Disease6
E Carwile LeRoy, MD6
Imaging of Pulmonary Manifestations of Connective Tissue Disease6
The Impact of Pediatric Rheumatic Diseases on Sexual Health, Family Planning, and Pregnancy5
Biomarkers in Childhood-Onset Systemic Lupus Erythematosus5
Contributors5
Forthcoming Issues5
Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis5
The Challenges of New Biologic Therapies in Pediatrics5
Beyond Coronary Artery Disease5
Copyright5
The Power of Systems Biology5
Antinuclear Antibody Testing for the Diagnosis of Systemic Lupus Erythematosus5
Environmental Triggers for Rheumatic Disease: From “Why Did I Get This?” to “How Can We Prevent This?”4
Role of Environment in Pediatric Rheumatic Diseases4
Copyright4
Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk4
Cardiovascular Health in Pediatric Rheumatologic Diseases4
CARRA4
The Role of Psychology in Pediatric Rheumatic Diseases4
Treatment Guidelines in Pediatric Rheumatic Diseases4
SARS-CoV-2 Infection and COVID-19 in Children4
Environmental Risk Factors for Osteoarthritis: The Impact on Individuals with Knee Joint Injury4
Genetic Defects in Early-Onset Inflammatory Bowel Disease4
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases4
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases4
Updates in Systemic Sclerosis Treatment and Applicability to Pediatric Scleroderma4
Dual-Energy Computed Tomography Applications in Rheumatology4
Treatment Guidelines in Gout4
Management and Cure of Gouty Arthritis4
Imaging in Inflammatory Bowel Disease3
Pediatric Rheumatology Comes of Age: Part I3
Expanding IPEX: Inborn Errors of Regulatory T Cells3
Forthcoming Issues3
Technology to Assess and Treat Pain in Pediatric Rheumatology3
Patient Engagement in Pediatric Rheumatology Research3
Health Care Utilization3
Achieving Precision Medicine in Psoriatic Arthritis3
Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica3
Interferons in Systemic Lupus Erythematosus3
Contents3
Pediatric Rheumatic Disease in Lower to Middle-Income Countries3
Molecular Biomarkers and Clinical Predictors of Psoriatic Arthritis3
Interstitial Lung Disease3
Instrumental Substance Use Among Youth with Rheumatic Disease—A Biopsychosocial Model3
Precision Medicine2
Targeting Environmental Risks to Prevent Rheumatic Disease2
Pediatric Rheumatology Comes of Age: Part II2
COVID-19 in Pediatrics2
Forthcoming Issues2
Contributors2
Systemic Diseases and Heart Block2
Preface2
Contributors2
The GRADE Method2
Systemic Lupus Erythematosus Outcome Measures for Systemic Lupus Erythematosus Clinical Trials2
Early Sexual Health and Reproductive Implications in Pediatric Rheumatic Diseases2
Forthcoming Issues2
Perioperative Management of Rheumatic Disease and Therapies2
J. Claude Bennett, MD2
Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis2
Outcome Measures in Pediatric Rheumatic Disease2
Mental Health in Pediatric Rheumatology2
Lifestyle, Hormonal, and Metabolic Environmental Risks for Rheumatoid Arthritis2
Training the Next Generation of Rheumatologists2
Imaging in Juvenile Idiopathic Arthritis2
Forthcoming Issues2
Imaging in Rheumatology1
The Current and Future of Biomarkers of Immune Related Adverse Events1
Transitioning to Adulthood with a Rheumatic Disease1
Highlights of Interdisciplinary Care in Rheumatology1
Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis1
Targeted Treatment of Diseases of Immune Dysregulation1
Juvenile Fibromyalgia1
The Giants Of Rheumatology1
Forthcoming Issues1
Foreword1
Vasculitis1
Treatment of Vascular Complications in Systemic Sclerosis1
Multi-Organ System Screening, Care, and Patient Support in Systemic Sclerosis1
Foreword1
Treatment Guidelines in Vasculitis1
Contributors1
Suspecting and Diagnosing the Patient with Spondyloarthritis and What to Expect from Therapy1
Contributors1
The Promises and Perils of Social Media for Pediatric Rheumatology1
Nathan Zvaifler1
Cardiovascular Disease in Large Vessel Vasculitis1
Treatment of Inflammatory Arthritis in Systemic Sclerosis1
Long COVID for the Rheumatologist1
Axial Imaging in Spondyloarthritis1
Treatment Update in Systemic Lupus Erythematous1
Forthcoming Issues1
Recent Updates in Juvenile Spondyloarthritis1
Pediatric Rheumatology Comes of Age: Part I1
Gerald P Rodnan1
Lessons from Carl M. Pearson 1919 – 19810
Gastrointestinal Tract Considerations: Part II0
Managing Cardiovascular Risk in Patients with Rheumatic Disease0
The Role of Imaging in Diagnosis and Monitoring of Large Vessel Vasculitis0
Forthcoming Issues0
Understanding the Spectrum of Immune Dysregulation Manifestations in Autoimmune Lymphoproliferative Syndrome and Autoimmune Lymphoproliferative Syndrome-like Disorders0
Best Approaches to the Care of Systemic Sclerosis Patients0
Vascular, Soft Tissue, and Musculoskeletal Imaging in Systemic Sclerosis0
Forthcoming Issues0
Systemic Autoinflammatory Diseases0
Juvenile Idiopathic Arthritis Treatment Updates0
Edmund Lawrence Dubois (1923–1985)0
Patient Experience of Systemic Sclerosis–Related Calcinosis0
Emerging Concepts in Immune Dysregulation0
The Meaningful Role of Patients, and Other Stakeholders in Clinical Practice Guideline Development0
Mental Health Considerations in Chronic Disease0
Naomi Rothfield, MD, MACR0
How the American College of Rheumatology Develops Guidelines0
Interventions to Improve COVID-19 Vaccine Hesitancy0
Lessons on Telemedicine in Rheumatology0
Lupus Cohorts0
Newer Immunosuppressants for Rheumatologic Disease0
Lung Microbiome in Autoimmune-Associated Interstitial Lung Disease0
The Future of Vasculitis0
Isolated Aortitis0
Contents0
Cardiovascular Complications of Chronic Rheumatic Diseases0
Eric Bywaters and Barbara Ansell0
Myocardial Involvement in Systemic Autoimmune Rheumatic Diseases0
Contents0
Gut and Joint Microbiomes0
Considerations for Coronavirus Disease 2019 Vaccination Among B-Cell-Depleted Patients0
Systemic Lupus Erythematosus Risk0
Contributors0
Scleroderma Skin0
Role of Lipoprotein Levels and Function in Atherosclerosis Associated with Autoimmune Rheumatic Diseases0
Central Nervous System Imaging in Rheumatic Diseases0
Environmental Triggers for Rheumatic Diseases0
Immune Checkpoint Inhibitor-induced Sicca Syndrome0
Flares of Systemic Autoimmune Rheumatic Disease Following Coronavirus Disease 2019 Vaccination0
Contributors0
Using the Electronic Health Record to Enhance Care in Pediatric Rheumatology0
Pediatric Rheumatology Comes of Age: Part I0
Environmental Risks for Inflammatory Myopathies0
Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis0
Innovative Trials and New Opportunities in SLE0
Abnormal Mitochondrial Physiology in the Pathogenesis of Systemic Lupus Erythematosus0
Copyright0
Emerging Concepts in Immune Dysregulation0
New and Emerging Rheumatic Diseases0
Contents0
Suppressor of Cytokine Signaling 1 Haploinsufficiency0
John R. Ward, MD: Pioneer—Clinical Trials in Rheumatology0
Copyright0
The Temporomandibular Joint in Juvenile Idiopathic Arthritis0
Ear, Nose, and Throat Manifestations of Vasculitis and Other Systemic Autoimmune Diseases0
Contents0
Foreword0
Axial Psoriatic Arthritis0
Challenges in Developing Treatment Guidelines in Psoriatic Arthritis0
Copyright0
Rheumatology Pearls for the Primary Care Physician0
Environmental Triggers for Rheumatic Diseases0
Giant Cell Arteritis and Polymyalgia Rheumatica0
Imaging Revolutions in Modern Rheumatology0
The Impact of Coronavirus Disease 2019 on Patients Living with Rheumatic Diseases0
Forthcoming Issues0
Environmental Triggers for Vasculitis0
Type I Interferonopathies0
Vasculitis and Pregnancy0
Updates on Juvenile Dermatomyositis from the Last Decade: Classification to Outcomes0
Preventative Care in Scleroderma0
Juvenile Localized Scleroderma0
Forthcoming Issues0
Hal Holman of Stanford0
New Developments in Imaging in Crystalline Arthritis0
Review of Immunologic Manifestations of COVID-19 Infection and Vaccination0
Pre-existing Autoimmune Diseases and Immune Checkpoint Inhibitors for Cancer Treatment: Considerations About Initiation, Flares, Immune-Related Adverse Events, and Cancer Progression0
Forthcoming Issues0
The Emerging Telehealth Landscape in Pediatric Rheumatology0
Pediatric Rheumatology Comes of Age: Part II0
Lupus0
Combined Dermatology/Rheumatology Clinics for Management of Psoriatic Disease0
Vasculitis Mimics and Other Related Conditions0
Rheumatic Immune-related Adverse Events0
Scleroderma: Best Approaches to Patient Care0
Environmental Risks for Spondyloarthropathies0
Environmental Risks for Systemic Sclerosis0
Rheumatoid Arthritis0
Guideline Development and Implementation in Rheumatic Disease0
Imaging of Rheumatic Diseases Affecting the Lower Limb0
Immunotherapy Toxicity Management in Clinical Practice0
Forthcoming Issues0
Central Nervous System Vasculitis0
The Burden of Post-Acute Sequelae of Coronavirus Disease 2019 in Individuals with Rheumatic Diseases0
Management of Pregnancy in Lupus0
0.057575941085815